We found 163 records for "Licensing / acquisition"

Articles

Does the drug industry need a new pricing model?

12th January 2015

 Does the drug industry need a new pricing model?Articles

Various approaches have been taken to try to balance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term. Advances in drug development are...

Read more

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

News

AbbVie swoops for Pharmacyclics in $21bn takeover

5th March 2015

 AbbVie swoops for Pharmacyclics in $21bn takeoverNews

Johnson & Johnson has missed out on acquiring its marketing partner Pharmacyclics after AbbVie snatched the company from under its nose with a $21 billion takeover.The acquisition of Pharmacyclics and...

Read more

BMS keeps foot on immuno-oncology accelerator

4th March 2015

 BMS keeps foot on immuno-oncology acceleratorNews

A filing for anti-PD-1 drug Opdivo in lung cancer, plus three new licensing and acquisition deals, shows Bristol-Myers Squibb (BMS) has no intention of slowing its immuno-oncology drive.The US FDA...

Read more

GSK has most to prove after $16 bn Novartis deal

2nd March 2015

 GSK has most to prove after $16 bn Novartis dealNews

The $16 billion dollar 'asset swap' deal between GlaxoSmithKline (GSK) and Novartis has been formally completed today, with the UK-headquartered company exchanging its oncology portfolio for the Swiss firm's vaccines...

Read more

Is Pharmacyclics weighing up a sale?

26th February 2015

 Is Pharmacyclics weighing up a sale? News

Shares in Pharmacyclics leapt yesterday on speculation that the company is considering a sale, with Johnson & Johnson (J&J) considered the most likely buyer.Pharmacyclics is riding high at the moment,...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

Medical Device and Diagnostic Intellectual Property and Patent Strategy Conference

9th March 2015

Medical Device and Diagnostic Intellectual Property and Patent Strategy Conference

Examine recent case law, process changes, and the latest industry trends that impact medical device and diagnostic organizations for developing and preserving intellectual property and patents....

Read more

Pharma & Biotech Patent Litigation

19th March 2015 - 20th March 2015

Pharma & Biotech Patent Litigation

Our 2015 Pharma & Biotech Patent Litigation Conference will focus on the practical solutions to the current challenges facing pharma companies, patent attorneys, legal practitioners and regulatory officers. You...

Read more

BioPharma Asia Convention 2015

23rd March 2015 - 25th March 2015

BioPharma Asia Convention 2015

Asia’s biopharmaceutical industry is entering a period of opportunity; the need for industrial collaborations to foster innovation and change has never been more important. The 8th BioPharma Asia Convention is...

Read more

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

30th March 2015 - 31st March 2015

The 2nd IP Counsel Exchange on Post-Grant Patent Challenges at the PTAB

*The first in-house/corporate counsel attend for free* Join your in-house peers at the Post-Grant Patent Challenges at the PTAB on March 30-31 at San Jose City Hall, the future home...

Read more

Press Releases

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more